Catalyzing
immunotherapy
CatalYm has identified GDF-15 as a key cancer therapy resistance mechanism and is developing a safe and efficacious immune therapy for solid tumors.
Our latest news &
where to connect
FASEB Science Research Conferences - TGF-β Superfamily
July 21 - July 25, 2024
Niagara Falls, NY, USA